Helus Pharma
1 known investors
Helus Pharma develops novel serotonergic agonist therapies to treat mental health conditions including generalized anxiety disorder. The company uses a proprietary drug development platform to create next-generation psychiatric treatments with novel delivery formulations.
Founders & leadership
ES
Eric SoCo-Founder, Executive Chairman & Interim Chief Executive Officer